Barriers to evidence-based treatment for children with attention-deficit/hyperactivity disorder

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 7, Issue 1, 2015, Pages 49-74

  Corkum, Penny ^a,b,c   Bessey, Meredith ^a   McGonnell, Melissa ^d   Dorbeck, Anders ^e  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

^c ADHD Clinic   (Canada)

^d MOUNT SAINT VINCENT UNIVERSITY   (Canada)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

ADHD; Barriers; Perceptions; Treatment; Treatment adherence; Treatment utilization

Indexed keywords

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE TO HEALTH; CHILD; EVIDENCE BASED MEDICINE; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE;

EID: 84939878211     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-014-0152-z     Document Type: Article

References (102)

1. *Ahmed R, Borst J, Wei YC, Aslani P (2013a) Parents’ perspectives about factors influencing adherence to pharmacotherapy for ADHD. J Atten Disord. doi:10.1177/1087054713499231
2. Ahmed R, McCaffery KJ, Aslani P (2013) Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 23:163–178
3. American Academy of Child and Adolescent Psychiatry (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894–921
4. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn. (revised). APA, Washington
5. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. (text revised). APA, Washington
6. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. APA, Washington
7. *Angold A, Messer SC, Stangl D, Farmer EM, Costello EJ, Burns BJ (1998) Perceived parental burden and service use for child and adolescent psychiatric disorders. Am J Public Health 88:75–80
8. *Arcia E, Fernandez MC, Jaquez M (2004) Latina mothers’ stances on stimulant medication: complexity, conflict, and compromise. J Dev Behav Pediatr 25:311–317
9. *Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC, Abikoff HB, Comarda A, Conners CK, Elliott GR, Greenhill LH, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal T (2003) Effects on ethnicity on treatment attendance, stimulant response/dose, & 14-month outcome in ADHD. J Consult Clin Psychol 71:713–727
10. *Atzori P, Usala T, Carucci S, Danjou F, Zuddas A (2009) Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study. J Child Adolesc Psychopharmacol 19:673–681
11. *Bailey RK, Owens DL (2005) Overcoming challenges in the diagnosis and treatment of attention-deficit/hyperactivity disorder in African Americans. J Natl Med Assoc 97:5S–10S
12. *Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ (2006) Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr 27:1–10
13. *Barner JC, Khoza S, Oladapo A (2011) ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Curr Med Res Opin 27:13–22
14. *Beck MH, Cataldo M, Slifer KJ, Pulbrook V, Guhman JK (2005) Teaching children with attention deficit hyperactivity disorder (ADHD) and autistic disorder (AD) how to swallow pills. Clin Pediatr 44:515–526
15. *Bennett DS, Power TJ, Rostain AL, Carr DE (1996) Parent acceptability and feasibility of ADHD interventions: assessment, correlates, and predictive validity. J Pediatr Psychol 21:643–657
16. *Berger-Jenkins E, McKay M, Newcorn J, Bannon W, Laraque D (2012) Parent medication concerns predict underutilization of mental health services for minority children with ADHD. Clin Pediatr 51:65–76
17. *Bird HR, Shrout PE, Duarte CS, Shen S, Bauermeister JJ, Canino G (2008) Longitudinal mental health service and medication use for ADHD among Puerto Rican youth in two contexts. J Am Acad Child Adolesc Psychiatry 47:879–889
18. *Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF (2009) Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder. Pediatrics 124:580–589
19. *Brown RT, Borden KA, Wynne ME, Spunt AL, Clingerman SR (1987) Compliance with pharmacological and cognitive treatments for attention deficit disorder. J Am Acad Child Adolesc Psychiatry 26:521–526
20. *Brownell MD, Mayer T, Chateau D (2006) The incidence of methylphenidate use by Canadian children: what is the impact of socioeconomic status and urban or rural residence. Can J Psychiatry 51:847–854
21. *Bussing R, Gary FA, Mills TL, Garvan CW (2003a) Parental explanatory models of ADHD: gender and cultural variations. Soc Psychiatr Epidemiol 38:563–575
22. *Bussing R, Gary FA, Mills TL, Garvan CW (2007) Cultural variations in parental health beliefs, knowledge, and information sources related to attention-deficit/hyperactivity disorder. J Fam Issues 28:291–318
23. *Bussing R, Koro-Ljungberg ME, Gary F, Mason D, Garavan C (2005) Exploring help-seeking for ADHD symptoms: a mixed-methods approach. Harv Rev Psychiatry 13:85–101
24. *Bussing R, Zima BT, Belin TR (1998) Differential access to care for children with ADHD in special education programs. Psychiatr Serv 49:1226–1229
25. *Bussing R, Zima BT, Gary FA, Garvan CW (2003b) Barriers to detection, help-seeking, and service use for children with ADHD symptoms. J Behav Health Serv Res 30:176–189
26. Calvert SC, Johnston C (1990) Acceptability of treatments for child behaviour problems: issues and implications for future research. J Clin Child Psychol 19:61–75
27. *Chan E, Zhan C, Homer CJ (2002) Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 156:504–511
28. *Charach A, Ickowicz A, Schachar R (2004) Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43:559–567
29. Chronis AM, Jones HA, Raggi VL (2006) Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clin Psychol Rev 26:486–502
30. *Coletti DJ, Pappadopulos E, Katsiotas NJ, Berest A, Jensen PS, Kafantaris V (2012) Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 22:226–237
31. *Corkum P, Rimer P, Schachar R (1999) Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: impact on enrollment and adherence to a 12-month treatment trial. Can J Psychiatry 44:1043–1048
32. *Cormier E (2012) How parents make decisions to use medication to treat their child’s ADHD: a grounded theory study. J Am Psychiatr Nurses Assoc 18:345–356
33. Cromer BA, Tarnowski KJ (1989) Noncompliance in adolescents: a review. J Dev Behav Pediatr 10:207–215
34. Cuffe SP, Moore CG, McKeown R (2009) ADHD and health services utilization in the National Health Interview Survey. J Atten Disord 12:330–340
35. Daly BP, Creed T, Xanthopoulos M, Brown RT (2007) Psychosocial treatments for children with attention deficit/hyperactivity disorder. Neuropsychol Rev 17:73–89
36. Danforth S, Navarro V (2001) Hyper talk: sampling the social construction of ADHD in everyday language. Anthropol Educ Q 32:167–190
37. *Davis CC, Claudius M, Palinkas LA, Wong JB, Leslie LK (2012) Putting families in the center: family perspectives on decision making and ADHD and implications for ADHD care. J Atten Disord 16:675–684
38. *dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R (2006) Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community. J Behav Health Serv Res 33:423–430
39. *dosReis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW, Ellwood LC (2003) Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr 24:155–162
40. *Dreyer AS, O’Laughlin L, Moore J, Milam Z (2010) Parental adherence to clinical recommendations in an ADHD evaluation clinic. J Clin Psychol 66:1101–1120
41. ® methylphenidate in children with ADHD. J Atten Disord 11:157–166
42. Fitzcharles M, DaCosta D, Ware MA, Shir Y (2009) Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. J Pain 10:300–305
43. Ford T, Fowler T, Langley K, Whittinger N, Thapar A (2008) Five years on: public sector service use related to mental health in young people with ADHD or hyperkinetic disorder five years after diagnosis. Child Adolesc Ment Health UK 13:122–129
44. *Gage JD, Wilson LD (2000) Acceptability of attention-deficit/hyperactivity disorder interventions: a comparison of parents. J Atten Disord 4:174–182
45. *Gau SSF, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS (2008) National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry 69:131–140
46. *Gau SSF, Shen H, Chou M, Tang C, Chiu Y, Gau C (2006) Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 16:286–297
47. *Graetz BW, Sawyer MG, Baghurst P, Hirte C (2006) Gender comparisons of service use among youth with attention-deficit/hyperactivity disorder. J Emot Behav Disord 14:2–11
48. *Guevera J, Lozano P, Wickizer T, Mell L, Gephart H (2001) Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 108:71–78
49. *Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM (2013) Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Prefer Adherence 7:987–995
50. Huang H, Chao C, Tu C, Yang P (2003) Behavioral parent training for Taiwanese parents of children with attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci 57:275–281
51. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD (1999) Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 38:797–804
52. Johnston C, Fine S (1993) Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction and compliance. J Pediatr Psychol 18:717–773
53. Kaiser NM, Pfiffner LJ (2011) Evidence-based psychosocial treatments for childhood ADHD. Psychiatr Ann 41:9–15
54. Kazdin AE (1981) Acceptability of child treatment techniques: the influence of treatment efficacy and adverse side-effects. Behav Ther 12:493–506
55. *Kelleher JK, Childs GE, Harmon JS (2001) Health care costs for children with attention-deficit/hyperactivity disorder. Econ Neurosci 3:60–63
56. *Krain AL, Kendall PC, Power TJ (2005) The role of treatment acceptability in the initiation of treatment for ADHD. J Atten Disord 9:425–434
57. Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S (2004) International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14:11–28
58. *Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O’Brien P (2001) Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. J Am Med Assoc 285:60–66
59. *Liu C, Robin AL, Brenner S, Eastman J (1991) Social acceptability of methylphenidate and behaviour modification for treating attention deficit hyperactivity disorder. Pediatrics 88:560–565
60. Mackner LM, McGrath AM, Stark LJ (2001) Dietary recommendations to prevent and manage chronic pediatric health conditions: adherence, intervention, and future directions. J Dev Behav Pediatr 22:130–143
61. MacNaughton KL, Rodrigue JR (2001) Predicting adherence to recommendations by parents of clinic-referred children. J Consult Clin Psychol 69:262–270
62. *Maniadaki K, Sonuga-Barke E, Kakouros E, Karaba R (2006) Parental beliefs about the nature of ADHD behaviours and their relationship to referral intentions in preschool children. Child Care Health Dev 33:188–195
63. *Marcus SC, Wan GJ, Kemner JE, Olfsan M (2005) Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 159:572–578
64. *Miller AR, Lalonde CE, McGrail KM (2004) Children’s persistence with methylphenidate therapy: a population-based study. Can J Psychiatry 49:761–768
65. *Miltenberger RG, Parrish JM, Rickert V, Kohr M (1989) Assessing treatment acceptability with consumers of outpatient child behavior management services. Child Fam Behav Ther 11:35–44
66. *Monastra VJ (2005) Overcoming the barriers to effective treatment for attention- deficit/hyperactivity disorder: a neuro-educational approach. Int J Psychophysiol 58:71–80
67. MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073–1086
68. MTA Cooperative Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 113:762–769
69. *Ohan JL, Johnston C (2000) Reported rates of adherence to medication prescribed for adolescents’ symptoms of ADHD. Clin Child Psychol Psychiatry 5:581–593
70. *Owens PL, Hoagwood K, Horwitz SM, Leaf PJ, Poduska JM, Kellam SG, Ialongo NS (2002) Barriers to children’s mental health services. J Am Acad Child Adolesc Psychiatry 41:731–738
71. *Palli SR, Kamble PS, Chen H, Aparasu RR (2012) Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 22:139–148
72. Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-MacLean L, Morse G (2005) A dose-ranging study of a methylphenidate transdermal system in children with ADHD. J Am Acad Child Adolesc Psychiatry 44:522–529
73. Pelham WE, Wheeler T, Chronis A (1998) Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 27:190–205
74. Perrin JM, Fluet C, Kuhlthau KA (2005) Benefits for employees with children with ADHD: findings from the collaborative employee benefit study. J Dev Behav Pediatr 26:3–8
75. *Power TJ, Hess LE, Bennett DS (1995) The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers. J Dev Behav Pediatr 16:238–243
76. *Ray GT, Levine P, Croen LA, Bokhari FAS, Hu T, Habel LA (2006) Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity. Arch Pediatr Adolesc Med 160:1063–1069
77. Reimers TM, Wacker DP, Koeppl G (1987) Acceptability of behavioral interventions: a review of the literature. School Psychol Rev 16:212–227
78. *Reimers TM, Wacker DP, Cooper LJ, DeRaad AO (1992) Clinical evaluation of the variables associated with treatment acceptability and their relation to compliance. Behav Disord 18:67–76
79. *Rieppi R, Greenhill LL, Ford RE, Chuang S, Wu M, Davies M, Abikoff HB, Arnold LE, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T (2002) Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry 41:269–277
80. Rostain A, Power T, Atkins M (1993) Assessing parents’ willingness to pursue treatment for children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 32:175–181
81. *Rothenberger A, Becker A, Breuer D, Döpfner M (2011) An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. Eur Child Adolesc Psychiatry 20:S257–S265
82. *Sawyer MG, Rey JM, Arney FM, Whitham JN, Clark JJ, Baghurst PA (2004) Use of health and school-based services in Australia by young people with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:1355–1363
83. *Sayal K, Goodman R, Ford T (2006) Barriers to the identification of children with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 47:744–750
84. *Sayal K, Taylor K, Beecham J (2003) Parental perceptions of problems and mental health service use for hyperactivity. J Am Acad Child Adolesc Psychiatry 42:1410–1414
85. Schachar R (2009) Attention Deficit Hyperactivity Disorder in children, adolescents, and adults. Contin Lifelong Learn Neurol 15:78–97
86. Scheffler RM, Hinshaw SP, Modrek S, Levine P (2007) The global market for ADHD medications. Health Aff 26:450–457
87. Schmitz MF, Filippone P, Edelman EM (2003) Social representations of attention deficit/hyperactivity disorder, 1988–1997. Cult Psychol 9:383–406
88. *Schneider BW, Gerdes AC, Haack LM, Lawton KE (2013) Predicting treatment dropout in parent training interventions for families of school-aged children with ADHD. Child Fam Behav Ther 35:144–169
89. Shen H, Edwards H, Courtney M, McDowell J, Wei J (2013) Barriers and facilitators to diabetes self-management: perspectives of older community dwellers and health professionals in China. IJNP 19:627–635
90. *Sitholey P, Agarwal V, Chamoli S (2011) A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder. Indian J Psychiatry 53:41–44
91. Staller JA (2006) Diagnostic profiles in outpatient child psychiatry. Am J Orthopsychiatry 76:98–102
92. *Stevens J, Harman J, Kelleher K (2005) Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol. 15:88–96
93. Swanson J (2003) Compliance with stimulants for attention deficit hyperactivity disorder: issues and approaches for improvement. CNS Drugs 17:117–131
94. *Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A (2003) Attention-deficit/hyperactivity disorder: increases costs for patients and their families. J Am Acad Child Adolesc Psychiatry 42:1415–1423
95. *Tarnowski KJ, Simonian SJ, Park A, Bekeny P (1992) Acceptability of treatments for child behavioral disturbance: race, socioeconomic status, and multicomponent treatment effects. Child Fam Behav Ther 14:25–37
96. *Thiruchelvam D, Charach A, Schachar RJ (2001) Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 40:922–928
97. Vanheusden K, van der Ende J, Mulder CL, van Lenthe FJ, Verhulst FC, Mackenbach JP (2008) The use of mental health services among young adults with emotional and behavioural problems: equal use for equal needs? Soc Psychiatry Psychiatr Epidemiol 43:808–815
98. Vaughan BS, March JS, Kratochvil CJ (2012) The evidence-based pharmacological treatment of paediatric ADHD. Int J Neuropsychopharmacol 15:27–39
99. Wells A, Lagomasino IT, Palinkas LA, Green JM, Gonzalez D (2013) Barriers to depression treatment among low-income, Latino emergency department patients. Community Ment Health J 49:412–418
100. *Wilson LJ, Jennings JN (1996) Parents’ acceptability of alternative treatments for attention-deficit/hyperactivity disorder. J Atten Disord 1:114–121
101. *Zima BT, Bussing R, Tang L, Zhang L (2012) Do parent perceptions predict continuity of publicly funded care for attention-deficit/hyperactivity disorder? Pediatrics 131:S50–S59
102. Zindani GN, Streetman DD, Streetman DS, Nasr SZ (2006) Adherence to treatment in children and adolescent patients with cystic fibrosis. J Adolesc Health 38:13–17